CytomX Therapeutics Inc (CTMX)
0.9925
0.00 (0.00%)
USD |
NASDAQ |
Oct 31, 16:00
0.9948
0.00 (0.00%)
After-Hours: 20:00
CytomX Therapeutics Max Drawdown (5Y): 96.52% for Sept. 30, 2024
Max Drawdown (5Y) Chart
Historical Max Drawdown (5Y) Data
| Date | Value |
|---|---|
| September 30, 2024 | 96.52% |
| August 31, 2024 | 96.52% |
| July 31, 2024 | 96.52% |
| June 30, 2024 | 96.52% |
| May 31, 2024 | 96.52% |
| April 30, 2024 | 96.52% |
| March 31, 2024 | 96.52% |
| February 29, 2024 | 96.52% |
| January 31, 2024 | 96.52% |
| December 31, 2023 | 96.52% |
| November 30, 2023 | 96.52% |
| October 31, 2023 | 96.52% |
| September 30, 2023 | 96.52% |
| August 31, 2023 | 96.52% |
| July 31, 2023 | 96.52% |
| June 30, 2023 | 96.52% |
| May 31, 2023 | 96.52% |
| April 30, 2023 | 96.52% |
| March 31, 2023 | 96.52% |
| February 28, 2023 | 96.52% |
| January 31, 2023 | 96.52% |
| December 31, 2022 | 96.52% |
| November 30, 2022 | 96.52% |
| October 31, 2022 | 96.41% |
| September 30, 2022 | 96.41% |
| Date | Value |
|---|---|
| August 31, 2022 | 96.41% |
| July 31, 2022 | 96.41% |
| June 30, 2022 | 95.53% |
| May 31, 2022 | 95.53% |
| April 30, 2022 | 95.00% |
| March 31, 2022 | 92.20% |
| February 28, 2022 | 89.45% |
| January 31, 2022 | 89.45% |
| December 31, 2021 | 89.45% |
| November 30, 2021 | 89.45% |
| October 31, 2021 | 89.45% |
| September 30, 2021 | 89.45% |
| August 31, 2021 | 89.45% |
| July 31, 2021 | 89.45% |
| June 30, 2021 | 89.45% |
| May 31, 2021 | 89.45% |
| April 30, 2021 | 89.45% |
| March 31, 2021 | 89.45% |
| February 28, 2021 | 89.45% |
| January 31, 2021 | 89.45% |
| December 31, 2020 | 89.45% |
| November 30, 2020 | 89.45% |
| October 31, 2020 | 89.45% |
| September 30, 2020 | 89.45% |
| August 31, 2020 | 89.45% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
84.89%
Minimum
Nov 2019
96.52%
Maximum
Nov 2022
92.72%
Average
95.00%
Median
Apr 2022
Max Drawdown (5Y) Benchmarks
| NovaBay Pharmaceuticals Inc | 99.98% |
| Palatin Technologies Inc | 97.31% |
| iBio Inc | 99.97% |
| Theriva Biologics Inc | 99.81% |
| Oragenics Inc | 99.58% |
Max Drawdown (5Y) Related Metrics
| Alpha (5Y) | -47.18 |
| Beta (5Y) | 1.037 |
| Annualized Standard Deviation of Monthly Returns (5Y Lookback) | 85.64% |
| Historical Sharpe Ratio (5Y) | -0.3854 |
| Historical Sortino (5Y) | -0.88 |
| Monthly Value at Risk (VaR) 5% (5Y Lookback) | 31.18% |